SynthesisAntimicrobial resistance and infection control2026
Surveillance of antibiotic-resistant bacteria integrating whole genome sequencing and epidemiological information - a global, systematic review, 2012-2023.
Synthesis in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpidemiologic surveillance is one pillar in the global efforts to stop the spread of antibiotic-resistant bacteria (ARB) and increasingly includes whole genome sequencing (WGS). However, no review systematically examined the characteristics of such surveillance systems until February 2025. We conducted a systematic review to identify and describe routine surveillance systems of ARB, that integrate WGS and epidemiological information.
methodsA protocol was developed and published on PROSPERO. We searched 8 databases and Google. Included articles needed to report on a national or subnational surveillance system and include epidemiological data as well as WGS of carbapenem-resistant or carbapenemase-producing Enterobacterales (CRE) or Acinetobacter spp., methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococci (VRE). Surveillance system characteristics were analysed narratively.
resultsFrom 13,142 searched articles, 41 were included. The publications were stratified by pathogen. The strata demonstrated similar WGS approaches with a predominance of short-read sequencing platforms. Typing methods mostly included multilocus sequence typing and single nucleotide polymorphism -based analyses for higher discrimination. Reported cluster thresholds showed a wide range of values within and between species. Across strata, there was often a low level of epidemiological data collection, such as exposure of cases, and integration in cluster analyses. WGS surveillance complemented with at least basic epidemiological data has been reported from all six WHO regions for CRE. However, fewer studies and no studies at all for MRSA and VRE were included from the African, Eastern Mediterranean and South-East Asian regions. The national coverage of surveillance ranged from 36% for MRSA to 56% for CRE.
conclusionWGS-based surveillance on ARB is employed worldwide with predominant use of short-read technology and largely consistent typing methods. Substantial variation in genomic clustering thresholds underscores the need for internationally harmonized standards for data analysis. Insufficient epidemiological information or lacking integration in the analysis of WGS data may reduce the ability to infer transmission pathways and identify outbreaks. To fully exploit the potential of WGS-based surveillance systems in this context for public health and contain current and prevent future outbreaks, we thus call for a routine collection of detailed epidemiological data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.